Primus Remedies Pvt Ltd
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.mg)
Voglow 0.3 GM3 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Voglow 0.3 GM3 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Voglow 0.3 GM3 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Voglow 0.3 GM3 Tablet SR.
Voglow 0.3 GM3 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Voglow 0.3 GM3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Voglow 0.3 GM3 Tablet SR is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Voglow 0.3 GM3 Tablet SR contains Glimepiride, Metformin, and Voglibose to treat type 2 diabetes mellitus (DM). It helps lower blood glucose levels in adults when taken along with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production in the liver and improves insulin sensitivity, and Voglibose inhibits alpha-glucosidase activity to lower postprandial (after meal) glucose levels. This combination is not suitable for treating Type 1 DM.
Common side effects include hypoglycemia, nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
This medicine should not be used if you have known allergies to its components or excipients. It's also unsuitable for patients with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, alcohol should not be taken along with Voglow 0.3 GM3 Tablet SR as it may lower blood sugar levels further and increase the risk of lactic acidosis.
Yes, Voglow 0.3 GM3 Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely if you miss or delay food, drink alcohol, exercise excessively, or take other antidiabetic medications simultaneously. Regular blood sugar monitoring is essential.
Store this medicine in its original packaging, tightly closed, following the directions on the label. Dispose of unused medication properly; it should not be consumed by pets or children.